Gandeeva Therapeutics
PrivateLast Round
Series A
Jan 13, 2022
Total Funding Raised
$40M
Company Overview
Gandeeva Therapeutics operates in Healthcare & Life Sciences and is based in Vancouver. Its latest recorded funding round was a Series A round in January 2022.
Gandeeva Therapeutics is a biotechnology company that leverages cryogenic electron microscopy and machine learning to develop novel therapeutics targeting protein-protein interactions.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gandeeva Therapeutics Comparables
Compare Gandeeva Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Baobab AiBIO | 85% | |
| Genesis Molecular AI | 81% | |
| Iambic Therapeutics | 80% |
For institutional investors. Book with your work email.
Gandeeva Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Gandeeva Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amplitude Ventures | Series A |
| Air Street Capital | Series A |
| Lux Capital | Series A |
| Obvious Ventures | Series A |
| Amgen Ventures | Series A |
| Leaps by Bayer | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors grew 94% MoM, reaching 1.3K.
- Jan 13, 2022
$40M round led by Lux Capital and Leaps by Bayer.
For institutional investors. Book with your work email.
Gandeeva Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gandeeva Therapeutics's valuation, stock price, and market status.
Is Gandeeva Therapeutics a public or private company?
Gandeeva Therapeutics is a private company.
What is the current stock price of Gandeeva Therapeutics?
Gandeeva Therapeutics is a private company, so its shares have no public market price. Caplight tracks Gandeeva Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gandeeva Therapeutics worth (valuation)?
Valuation information for Gandeeva Therapeutics is not publicly available.
Can I buy Gandeeva Therapeutics stock?
Gandeeva Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gandeeva Therapeutics's last funding round?
Gandeeva Therapeutics's most recent funding round was Series A on January 13, 2022.
Who are the main investors in Gandeeva Therapeutics?
Key investors in Gandeeva Therapeutics include Lux Capital, Leaps by Bayer.
Will Gandeeva Therapeutics IPO soon?
No public IPO plans have been announced for Gandeeva Therapeutics.
How can I track Gandeeva Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Gandeeva Therapeutics's shares on secondary markets.